Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia (clinicaltrials.gov) - Oct 2, 2026 - P=N/A | N=44 | Completed | Sponsor: Bristol-Myers Squibb | Active, not recruiting ➔ Completed
Trial completion • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
|